ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Gynecologic Oncology
Volume 101, Issue 1, April 2006, Pages 152-157
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (291 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.ygyno.2005.10.008    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2005 Elsevier Inc. All rights reserved.

Primary and metastatic mucinous adenocarcinomas of the ovary: Evaluation of the diagnostic approach using tumor size and laterality

Surapan Khunamornponga, Corresponding Author Contact Information, E-mail The Corresponding Author, Prapaporn Suprasertb, Suwalee Pojchamarnwiputhc, Wittanee Na Chiangmaic, Jongkolnee Settakorna and Sumalee Siriaunkgula

aDepartment of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand bDepartment of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand cDepartment of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Received 27 September 2005. 
Available online 21 November 2005.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Objective.

To evaluate the usefulness of the recently proposed algorithm (Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 2003; 27: 985–93 [5]) that classifies mucinous adenocarcinomas of the ovary as primary when they were unilateral ≥10 cm and as metastatic when they were unilateral <10 cm or bilateral.

Methods.

Malignant ovarian neoplasms, which were resected in Chiang Mai University Hospital between 1992 and 2003, were histologically reviewed. Mucinous adenocarcinomas involving the ovary were identified. The medical records and radiologic materials were reviewed in correlation with the pathologic features to identify the primary site.

Results.

There were 74 cases of mucinous adenocarcinomas; 16 were primary ovarian; 52, metastatic; and 6 of indeterminate primary site (primary versus metastatic). Primary mucinous adenocarcinomas had a mean size of 16.4 cm and bilateral involvement in 13%. Metastatic mucinous adenocarcinomas had a mean size of 11.7 cm and bilateral involvement in 77%. Excluding the 6 tumors of indeterminate primary site, the proposed algorithm correctly classified primary and metastatic tumors in 84% of 68 cases. Of 21 unilateral mucinous adenocarcinomas ≥10 cm, 62% were primary ovarian. Of 5 unilateral tumors <10 cm, 80% were metastatic. Of 42 bilateral mucinous adenocarcinomas, 95% were metastatic.

Conclusion.

The algorithm provided high accuracy in the overall prediction of primary and metastatic mucinous adenocarcinomas of the ovary, with major strength in the identification of metastatic tumors by bilaterality or size < 10 cm. However, the prediction of primary mucinous adenocarcinomas by unilaterality and size ≥ 10 cm was less reliable than previously reported. Due to the overlapping features between primary and metastatic tumors and the higher frequency of the latter, the possibility of metastases should always be borne in mind in the evaluation of mucinous adenocarcinomas of the ovary.

Keywords: Ovary; Mucinous tumor; Mucinous adenocarcinoma; Primary tumor; Metastatic tumor; Tumor size; Tumor laterality

Article Outline

Introduction
Materials and methods
Results
Discussion
References



Gynecologic Oncology
Volume 101, Issue 1, April 2006, Pages 152-157
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.